NCT06432296 2025-07-20Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 3 Active not recruiting312 enrolled